ITCI logo

Intra-Cellular Therapies (ITCI) Total Assets

Annual Total Assets

$728.29 M
-$26.48 M-3.51%

31 December 2023

ITCI Total Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Assets

$1.32 B
+$3.94 M+0.30%

30 September 2024

ITCI Quarterly Total Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ITCI Total Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-3.5%+84.5%
3 y3 years+1.5%+137.8%
5 y5 years+103.9%+372.1%

ITCI Total Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-3.5%+48.7%at high+170.3%
5 y5 years-3.5%+189.9%at high+427.3%
alltimeall time-3.5%>+9999.0%at high

Intra-Cellular Therapies Total Assets History

DateAnnualQuarterly
Sept 2024
-
$1.32 B(+0.3%)
June 2024
-
$1.32 B(+76.8%)
Mar 2024
-
$747.04 M(+2.6%)
Dec 2023
$728.29 M(-3.5%)
$728.29 M(+1.5%)
Sept 2023
-
$717.66 M(+0.6%)
June 2023
-
$713.60 M(-1.2%)
Mar 2023
-
$722.16 M(-4.3%)
Dec 2022
$754.78 M(+54.1%)
$754.78 M(-3.5%)
Sept 2022
-
$782.00 M(-3.7%)
June 2022
-
$811.91 M(-6.5%)
Mar 2022
-
$868.58 M(+77.3%)
Dec 2021
$489.92 M(-31.7%)
$489.92 M(-12.0%)
Sept 2021
-
$556.98 M(-11.0%)
June 2021
-
$625.70 M(-7.2%)
Mar 2021
-
$674.49 M(-6.0%)
Dec 2020
$717.31 M(+185.6%)
$717.31 M(-7.0%)
Sept 2020
-
$771.29 M(+74.9%)
June 2020
-
$440.93 M(-8.4%)
Mar 2020
-
$481.24 M(+91.6%)
Dec 2019
$251.19 M(-29.7%)
$251.19 M(-10.5%)
Sept 2019
-
$280.52 M(-9.5%)
June 2019
-
$309.86 M(-9.7%)
Mar 2019
-
$342.97 M(-4.0%)
DateAnnualQuarterly
Dec 2018
$357.21 M(-24.2%)
$357.21 M(-7.4%)
Sept 2018
-
$385.59 M(-6.4%)
June 2018
-
$412.07 M(-7.5%)
Mar 2018
-
$445.64 M(-5.5%)
Dec 2017
$471.49 M(+21.2%)
$471.49 M(+41.1%)
Sept 2017
-
$334.19 M(-4.4%)
June 2017
-
$349.54 M(-6.1%)
Mar 2017
-
$372.29 M(-4.3%)
Dec 2016
$388.90 M(-19.7%)
$388.90 M(-28.3%)
Sept 2016
-
$542.57 M(+21.2%)
June 2016
-
$447.60 M(-3.5%)
Mar 2016
-
$463.66 M(-4.2%)
Dec 2015
$484.10 M(+269.2%)
$484.10 M(-5.7%)
Sept 2015
-
$513.12 M(+140.4%)
June 2015
-
$213.40 M(-10.0%)
Mar 2015
-
$237.13 M(+80.9%)
Dec 2014
$131.11 M(+241.0%)
$131.11 M(-4.7%)
Sept 2014
-
$137.61 M(-2.6%)
June 2014
-
$141.34 M(-3.6%)
Mar 2014
-
$146.64 M(+281.4%)
Dec 2013
$38.45 M(>+9900.0%)
$38.45 M(-18.8%)
Sept 2013
-
$47.34 M(>+9900.0%)
June 2013
-
$0.00
Mar 2013
$4100.00
-

FAQ

  • What is Intra-Cellular Therapies annual total assets?
  • What is the all time high annual total assets for Intra-Cellular Therapies?
  • What is Intra-Cellular Therapies annual total assets year-on-year change?
  • What is Intra-Cellular Therapies quarterly total assets?
  • What is the all time high quarterly total assets for Intra-Cellular Therapies?
  • What is Intra-Cellular Therapies quarterly total assets year-on-year change?

What is Intra-Cellular Therapies annual total assets?

The current annual total assets of ITCI is $728.29 M

What is the all time high annual total assets for Intra-Cellular Therapies?

Intra-Cellular Therapies all-time high annual total assets is $754.78 M

What is Intra-Cellular Therapies annual total assets year-on-year change?

Over the past year, ITCI annual total assets has changed by -$26.48 M (-3.51%)

What is Intra-Cellular Therapies quarterly total assets?

The current quarterly total assets of ITCI is $1.32 B

What is the all time high quarterly total assets for Intra-Cellular Therapies?

Intra-Cellular Therapies all-time high quarterly total assets is $1.32 B

What is Intra-Cellular Therapies quarterly total assets year-on-year change?

Over the past year, ITCI quarterly total assets has changed by +$606.78 M (+84.55%)